Connection
David Schwartz to Adalimumab
This is a "connection" page, showing publications David Schwartz has written about Adalimumab.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.143 |
|
|
|
-
Louis EJ, Reinisch W, Schwartz DA, Löfberg R, Robinson AM, Berg S, Wang AW, Maa JF, Huang B, Pappalardo B. Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn's Disease: A Pooled Analysis of 11 Clinical Studies. Adv Ther. 2018 04; 35(4):563-576.
Score: 0.143